With FDA Approval for Advanced Lymphoma, Second CAR T-Cell Therapy Moves to the Clinic

Just a month after approving the first cancer therapy that uses genetically engineered immune cells collected from patients, the Food and Drug Administration (FDA) has now cleared a second such therapy.

UN agencies and countries unite against antimicrobial resistance

Over 100 country representatives and experts from the Food and Agriculture Organization of the United Nations (FAO), the World Organization for Animal Health (OIE) and WHO met in...